Renal Cancer

Survival Trends in Metastatic Renal Cell Carcinoma Across Therapeutic Eras and Histologic Subtypes. June 3, 2026

Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma? June 2, 2026

Sex-Specific Adverse Events and Cardiovascular Toxicity of Cabozantinib in Renal Cell Carcinoma: A Nine-Year Pharmacovigilance Study. June 1, 2026

Natural Products in Clear Cell Renal Cell Carcinoma: Rewiring the VHL-HIF Axis, Metabolic Plasticity, and Tumor-Immune Interactions. May 29, 2026

Histologic Heterogeneity of Metastases in Clear Cell Renal Cell Carcinoma with Sarcomatoid Differentiation. May 28, 2026

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial. May 27, 2026

Two decades of research on drug resistance in renal cell carcinoma. May 26, 2026

Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma. May 25, 2026

CT-Based Renal Artery Caliber Change as a Potential Imaging Marker of Treatment Response in Renal Cell Carcinoma; an Exploratory Imaging Study - Beyond the Abstract May 22, 2026

Association between systemic inflammatory response index and the prognosis of patients with localized and advanced renal cell carcinoma: a systematic review and meta-analysis. May 22, 2026

Co-overexpression of ELOVL2 and ELOVL5 promotes clear cell renal cell carcinoma progression through LIMK1-mediated cytoskeletal reorganization. June 3, 2026

Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity. June 2, 2026

Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma. June 1, 2026

Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis. May 29, 2026

Metastatic Patterns and Adverse Histopathologic Features in Advanced Renal Cell Carcinoma: A Five-Year Single-Center Retrospective Pathology Study. May 28, 2026

Overdiagnosis in renal cancer: the hidden consequence of modern imaging. May 27, 2026

Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring. May 26, 2026

Bibliometric study on hotspots and trends of immunotherapy for kidney cancer from 2014 to 2024. May 25, 2026

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma. May 22, 2026

Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations. May 21, 2026

Page 1 of 516